A retrospective study of second-line platinum containing chemotherapy in patients with endometrial cancer previously treated with platinum therapy

A retrospective study of second-line platinum containing chemotherapy in patients with endometrial cancer previously treated with platinum therapy - SGSG012 study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005051

Enrollment

800

Registered

2011-02-09

Start date

2010-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine corpus cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients with reurrent uterine corpus cancer who received platinum containing chemotherapy will include in this study. They were required to be histologically confirmd uterine corpus cancer and they hava to be received any platinum agent at first line chemoterapy except CCRT. Patients with uterine carcinosaicoma are included in this study.

Exclusion criteria

Exclusion criteria: Patients with uterine sarcoa.

Design outcomes

Primary

Measure	Time frame
Response rate	—

Secondary

Measure	Time frame
Overall survival period after recurrence	—

Countries

Japan

Contacts

Public ContactShoji Nagao

Saitama Medical University International Medical Center Gynecologic Oncology

s_naao@saitama-med.ac.jp042-984-4531

Outcome results